Supplemental Reference List (Studies Included in the Meta-Analysis)
Addolorato G, Leggio L, Ferrulli A, et al. Effectiveness and safety of baclofen for maintenance of alcohol
abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled
study. Lancet. 2007 Dec 8;370(9603):1915-1922.
Anton RF, Moak DH, Latham P, et al. Naltrexone combined with either cognitive behavioral or
motivational enhancement therapy for alcohol dependence. J Clin Psychopharmacol. 2005
Aug;25(4):349-537.
Anton RF, Moak DH, Waid LR, et al. Naltrexone and cognitive behavioral therapy for the treatment of
outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry. 1999;156(11):1758-1764.
Anton RF, O'Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for
alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006 May
3;295(17):2003-2017.
Balldin J, Berglund M, Borg S, et al. A 6-month controlled naltrexone study: combined effect with
cognitive behavioral therapy in outpatient treatment of alcohol dependence. Alcohol Clin Exp Res. 2003
Jul;27(7):1142-1149.
Baltieri DA, Daro FR, Ribeiro PL, et al. Comparing topiramate with naltrexone in the treatment of alcohol
dependence. Addiction. 2008 Dec;103(12):2035-2044.
Brady KT, Sonne S, Anton RF, et al. Sertraline in the treatment of co-occurring alcohol dependence and
posttraumatic stress disorder. Alcohol Clin Exp Res. 2005 Mar;29(3):395-401.
Chick J, Anton R, Checinski K, et al. A multicentre, randomized, double-blind, placebo-controlled trial of
naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcohol. 2000;35(6):587-593.
Evans SM, Levin FR, Brooks DJ, et al. A pilot double-blind treatment trial of memantine for alcohol
dependence. Alcohol Clin Exp Res. 2007 May;31(5):775-782.
Farren CK, Scimeca M, Wu R, et al. A double-blind, placebo-controlled study of sertraline with
naltrexone for alcohol dependence. Drug Alcohol Depend. 2009 Jan 1;99(1-3):317-321.
Furieri FA, Nakamura-Palacios EM. Gabapentin reduces alcohol consumption and craving: a
randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2007 Nov;68(11):1691-1700.
Gastpar M, Bonnet U, Boning J, et al. Lack of efficacy of naltrexone in the prevention of alcohol relapse:
results from a German multicenter study. J Clin Psychopharmacol. 2002;22(6):592-598.
Guardia J, Caso C, Arias F, et al. A double-blind, placebo-controlled study of naltrexone in the treatment
of alcohol-dependence disorder: results from a multicenter clinical trial. Alcohol Clin Exp Res.
2002;26(9):1381-1387.
Hammarberg A, Nylander I, Zhou Q, et al. The effect of acamprosate on alcohol craving and correlation
with hypothalamic pituitary adrenal (HPA) axis hormones and beta-endorphin. Brain Res. 2009 Dec
11;1305 Suppl:S2-6.
Hernandez-Avila CA, Modesto-Lowe V, Feinn R, et al. Nefazodone Treatment of Comorbid Alcohol
Dependence and Major Depression. Alcohol Clin Exp Res. 2004;28(3):433-440.
Hersh D, Van Kirk JR, Kranzler HR. Naltrexone treatment of comorbid alcohol and cocaine use disorders.
Psychopharmacology. 1998;139(1):44-52.
Hutchison KE, Ray L, Sandman E, et al. The effect of olanzapine on craving and alcohol consumption.
Neuropsychopharmacology. 2006 Jun;31(6):1310-1317.
Johnson BA, Ait-Daoud N, Aubin HJ, et al. A pilot evaluation of the safety and tolerability of repeat dose
administration of long-acting injectable naltrexone (Vivitrex) in patients with alcohol dependence.
Alcohol Clin Exp Res. 2004 Sep;28(9):1356-1361.
Johnson BA, Rosenthal N, Capece JA, et al. Topiramate for treating alcohol dependence: a randomized
controlled trial. JAMA. 2007 Oct 10;298(14):1641-1651.
Kampman KM, Pettinati HM, Lynch KG, et al. A double-blind, placebo-controlled pilot trial of quetiapine
for the treatment of Type A and Type B alcoholism. J Clin Psychopharmacol. 2007 Aug;27(4):344-351.
Kiefer F, Jahn H, Tarnaske T, et al. Comparing and combining naltrexone and acamprosate in relapse
prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry. 2003;60(1):9299.
Killeen TK, Brady KT, Gold PB, et al. Effectiveness of naltrexone in a community treatment program.
Alcohol Clin Exp Res. 2004 Nov;28(11):1710-1717.
Kranzler HR, Modesto-Lowe V, Nuwayser ES. Sustained-release naltrexone for alcoholism treatment: a
preliminary study. Alcohol Clin Exp Res. 1998 Aug;22(5):1074-1079.
Kranzler HR, Modesto-Lowe V, Van Kirk J. Naltrexone vs. nefazodone for treatment of alcohol
dependence. A placebo-controlled trial. Neuropsychopharmacology. 2000;22(5):493-503.
Kranzler HR, Wesson DR, Billot L. Naltrexone depot for treatment of alcohol dependence: a multicenter,
randomized, placebo-controlled clinical trial. Alcohol Clin Exp Res. 2004 Jul;28(7):1051-1059.
Latt NC, Jurd S, Houseman J, et al. Naltrexone in alcohol dependence: a randomised controlled trial of
effectiveness in a standard clinical setting. Med J Aust. 2002;176(11):530-534.
Lhuintre JP, Daoust M, Moore ND, et al. Ability of calcium bis acetyl homotaurine, a GABA agonist, to
prevent relapse in weaned alcoholics. Lancet. 1985 May 4;1(8436):1014-1016.
Lhuintre JP, Moore N, Tran G, et al. Acamprosate appears to decrease alcohol intake in weaned
alcoholics. Alcohol Alcohol. 1990;25(6):613-622.
McGrath PJ, Nunes EV, Stewart JW, et al. Imipramine treatment of alcoholics with primary depression: A
placebo-controlled clinical trial. Arch Gen Psychiatry. 1996 Mar;53(3):232-240.
Moak DH, Anton RF, Latham PK, et al. Sertraline and Cognitive Behavioral Therapy for Depressed
Alcoholics: Results of A Placebo-Controlled Trial. J Clin Psychopharmacol. 2003;23(6):553-562.
Morley KC, Teesson M, Reid SC, et al. Naltrexone versus acamprosate in the treatment of alcohol
dependence: A multi-centre, randomized, double-blind, placebo-controlled trial. Addiction. 2006
Oct;101(10):1451-1462.
Morris PL, Hopwood M, Whelan G, et al. Naltrexone for alcohol dependence: a randomized controlled
trial. Addiction. 2001;96(11):1565-1573.
Namkoong K, Lee BO, Lee PG, et al. Acamprosate in korean alcohol-dependent patients: a multi-centre,
randomized, double-blind, placebo-controlled study. Alcohol Alcohol. 2003;38(2):135-141.
O'Malley SS, Robin RW, Levenson AL, et al. Naltrexone alone and with sertraline for the treatment of
alcohol dependence in Alaska natives and non-natives residing in rural settings: a randomized controlled
trial. Alcohol Clin Exp Res. 2008 Jul;32(7):1271-1283.
Oslin DW, Lynch KG, Pettinati HM, et al. A placebo-controlled randomized clinical trial of naltrexone in
the context of different levels of psychosocial intervention. Alcohol Clin Exp Res. 2008 Jul;32(7):12991308.
Petrakis IL, O’Malley S, Rounsaville B, et al. Naltrexone augmentation of neuroleptic treatment in alcohol
abusing patients with schizophrenia. Psychopharmacology. 2004;172(3):291-297.
Petrakis IL, Poling J, Levinson C, et al. Naltrexone and Disulfiram in Patients with Alcohol Dependence
and Comorbid Psychiatric Disorders. Biological psychiatry. 2005;57(10):1128-1137.
Pettinati HM, Kampman KM, Lynch KG, et al. Gender differences with high-dose naltrexone in patients
with co-occurring cocaine and alcohol dependence. J Subst Abuse Treat. 2008 Jun;34(4):378-390.
Roy-Byrne PP, Pages KP, Russo JE, et al. Nefazodone treatment of major depression in alcoholdependent patients: a double-blind, placebo-controlled trial. J Clin Psychopharmacol. 2000
Apr;20(2):129-136.
Schmitz JM, Lindsay JA, Green CE, et al. High-dose naltrexone therapy for cocaine-alcohol dependence.
Am J Addict. 2009 Sep-Oct;18(5):356-362.
Shaw GK, Waller S, Majumdar SK, et al. Tiapride in the prevention of relapse in recently detoxified
alcoholics. Br J Psychiatry. 1994 Oct;165(4):515-523.
Sherwood Brown E, Garza M, Carmody TJ. A randomized, double-blind, placebo-controlled add-on trial
of quetiapine in outpatients with bipolar disorder and alcohol use disorders. J Clin Psychiatry. 2008
May;69(5):701-705.
Thomas SE, Randall PK, Book SW, et al. A complex relationship between co-occurring social anxiety and
alcohol use disorders: what effect does treating social anxiety have on drinking? Alcohol Clin Exp Res.
2008 Jan;32(1):77-84.
Tidey JW, Monti PM, Rohsenow DJ, et al. Moderators of naltrexone's effects on drinking, urge, and
alcohol effects in non-treatment-seeking heavy drinkers in the natural environment. Alcohol Clin Exp
Res. 2008 Jan;32(1):58-66.
Volpicelli JR, Clay KL, Watson NT, et al. Naltrexone in the treatment of alcoholism: predicting response
to naltrexone. J Clin Psychiatry. 1995;56 Suppl 7:39-44.
Volpicelli JR, Rhines KC, Rhines JS, et al. Naltrexone and alcohol dependence. Role of subject compliance.
Arch Gen Psychiatry. 1997 Aug;54(8):737-742.
Wetzel H, Szegedi A, Scheurich A, et al. Combination treatment with nefazodone and cognitivebehavioral therapy for relapse prevention in alcohol-dependent men: a randomized controlled study. J
Clin Psychiatry. 2004 Oct;65(10):1406-1413.